Chimaeric antigen receptor T-cell therapy for tumour immunotherapy

Chimaeric antigen receptor (CAR) T-cell therapies, as one of the cancer immunotherapies, have heralded a new era of treating cancer. The accumulating data, especially about CAR-modified T cells against CD19 support that CAR T-cell therapy is a highly effective immune therapy for B-cell malignancies....

Descripción completa

Detalles Bibliográficos
Autores principales: Sha, Huan-huan, Wang, Dan-dan, Yan, Da-li, Hu, Yong, Yang, Su-jin, Liu, Si-wen, Feng, Ji-feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2017
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5270315/
https://www.ncbi.nlm.nih.gov/pubmed/28053197
http://dx.doi.org/10.1042/BSR20160332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5270315/
https://www.ncbi.nlm.nih.gov/pubmed/28053197
http://dx.doi.org/10.1042/BSR20160332

Ejemplares similares